HIMS(Hims & Hers Health, Inc.) · 财务报表

HIMS(Hims & Hers Health, Inc.) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$271.88M$526.92M$872.00M$1.48B$2.35B
毛利润$204.49M$408.72M$714.95M$1.17B$1.73B
营业利润−$115.04M−$68.70M−$29.45M$61.90M$105.61M
净利润−$107.66M−$65.68M−$23.55M$126.04M$128.37M
经营现金流−$34.41M−$26.53M$73.48M$251.08M$300.01M
自由现金流—−$33.73M$46.98M$198.28M$57.41M
摊薄每股收益$-0.58$-0.32$-0.11$0.53$0.51

Hims & Hers Health, Inc. HIMS